Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Needham Maintains Buy on Sage Therapeutics, Lowers Price Target to $79


Benzinga | Oct 20, 2021 05:49AM EDT

Needham Maintains Buy on Sage Therapeutics, Lowers Price Target to $79

Needham analyst Ami Fadia maintains Sage Therapeutics (NASDAQ:SAGE) with a Buy and lowers the price target from $84 to $79.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC